| Category: |
Antibody |
| Concentration: |
09% sodium azide, 4 with 0, In 1X PBS pH 7 |
| Form: |
Purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
UBE2V1 |
| Host animal: |
Rabbit (Oryctolagus cuniculus) |
| Clonality: |
Polyclonal (rabbit origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, Mouse (Mus musculus) , we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
ELISA, WB |
| Recommended dilutions: |
Western blot: 1:1000 |
| Notes: |
Titration of the UBE2V1 antibody may be required due to differences in protocols and secondary/substrate sensitivity |
| Intented use: |
This UBE2V1 antibodyis to be used only for research purposes and not for diagnostics |
| Uniprot #: |
Q13404 |
| Purity: |
Purified |
| Description: |
A heterodimeric protein complex has been identified that links TRAF6 to IKK activation, Blockade of this polyubiquitin chain synthesis, Partial human intestinal epithelial cell cDNAs have been isolated containing the 3-primecoding sequence and 3-prime untranslated region of UBE2V1, TRAF6, These results unveil a new regulatory function for ubiquitin, UEV1 transcripts are downregulated upon differentiation of a colon carcinoma cell line, a RING domain protein, also called UEV1, also called UEV1A, also known as UBE2V1, and kidney, but not inhibition of the proteasome, functions together with UBC13/UEV1A to catalyze the synthesis of unique polyubiquitin chains linked through lysine-63 (K63) of ubiquitin, in which IKK is activated through the assembly of K63-linked polyubiquitin chains, or E2s) but lack the conserved cysteine residue critical to catalytic activity of E2s, prevents the activation of IKK by TRAF6, show sequence similarity to ubiquitin-conjugating enzymes (UBCs, skeletal muscle, with the highest levels in brain, 1 Constitutive expression of exogenous UEV1 protein in these colon carcinoma cells inhibits their capacity to differentiate upon confluence and induces changes in cell cycle behavior associated with inhibition of CDK1, 1 Northern blot analysis detected approximately 2, 1- and 2, 2 UEV1 does not have ubiquitin-conjugating activity in vitro, 3 Peptide mass fingerprinting analysis revealed that this complex is composed of the ubiquitin conjugating enzyme UBC13 and the UBC-like protein UBE2V1, 5-kb CROC1 transcripts in all human tissues examined, The CROC1 isoforms |
| Immunogen: |
A portion of amino acids 113-145 from the human protein was used as the immunogen for this UBE2V1 antibody |
| Storage: |
Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot the UBE2V1 antibody and store frozen at -20 deg |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
UBE2V1 |
| Short name: |
UBE2V1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
UBE2V1 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
12494 |
| Gene: |
UBE2V1 |
More about : UBE2V1 |
| Long gene name: |
ubiquitin conjugating enzyme E2 V1 |
| Synonyms gene: |
UBE2V |
| Synonyms gene name: |
ubiquitin-conjugating enzyme E2 variant 1 |
| Synonyms: |
UEV-1 CROC-1 UEV1A CROC1 |
| Locus: |
20q13, 13 |
| Discovery year: |
1998-03-20 |
| GenBank acession: |
U39360 |
| Entrez gene record: |
7335 |
| Pubmed identfication: |
9418904 9305758 |
| RefSeq identity: |
NM_021988 |
| Classification: |
Ubiquitin conjugating enzymes E2 |
| Havana BLAST/BLAT: |
OTTHUMG00000152626 |